<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: serum amyloid</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Weight loss led to reduction in inflammation</title>
   	 <description>Postmenopausal women who were overweight or obese and lost at least 5 percent of their body weight had a measurable reduction in markers of inflammation, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-05-weight-loss-reduction-inflammation.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 01 May 2012 03:50:01 EST</pubDate>
	 <guid isPermaLink="false">news255060558</guid>
	 
</item>
<item>
     <title>Amyloid beta in the brain of individuals with Alzheimer's disease</title>
   	 <description>While there may not be a consensus whether deposition of amyloid beta contributes to Alzheimer's disease or is a consequence of it, there is agreement that something else is promoting the process. Other proteins are often co-deposited with amyloid beta including serum amyloid P component. Recent evidence has suggested that SAP is elevated in Alzheimer's disease. Researchers from Keele University have shown that physiologically-significant concentrations of SAP promote the deposition of amyloid beta under conditions approaching those found in vivo.</description>
     <link>http://medicalxpress.com/news/2012-03-amyloid-beta-brain-individuals-alzheimer.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Fri, 30 Mar 2012 12:53:49 EST</pubDate>
	 <guid isPermaLink="false">news252330808</guid>
	 
</item>
<item>
     <title>Panel of serum biomarkers may reduce number of lung biopsies needed</title>
   	 <description>A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis. The biomarkers include: prolactin, transthyretin, thrombospondin-1, E-selectin, C-C motif chemokine 5, macrophage migration inhibitory factor, plasminogen activator inhibitor-1, receptor tyrosine-protein kinase erbB-2, Cyfra 21.1 and serum amyloid A. Further work is necessary to validate these exciting results.</description>
     <link>http://medicalxpress.com/news/2012-03-panel-serum-biomarkers-lung-biopsies.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 15 Mar 2012 11:50:40 EST</pubDate>
	 <guid isPermaLink="false">news251031034</guid>
	 
</item>
<item>
     <title>Inflammation, fatigue tied to omega-3 intake after breast cancer</title>
   	 <description>(HealthDay) -- For breast cancer survivors there may be an association between inflammation, intake of omega-3 polyunsaturated fatty acid (PUFA), and fatigue, with increased intake linked to decreased inflammation and fatigue, according to research published online March 12 in the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-03-inflammation-fatigue-tied-omega-intake.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 13 Mar 2012 16:30:01 EST</pubDate>
	 <guid isPermaLink="false">news250867530</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/inflammation.jpg" width="90" height="90" />
</item>


</channel>
</rss>
